Author:
Shukurov R. R.,Lobanova N. V.,Savinova I. N.,Vorobyova I. G.,Nurbakov A. A.,Ermolina L. V.,Orlova N. V.,Mosina A. G.,Antonova L. P.,Khamitov R. A.,Seryogin Yu. A.
Subject
Applied Microbiology and Biotechnology,Biochemistry
Reference22 articles.
1. REBPG for the Management of Anemia in Patients with Chronic Renal Failure, Anemiya, 2005, vol. 3, pp. 1–60.
2. Egrie, J.C. and Browne, J.K., Development and characterization of novel erythropoiesis stimulating protein (NESP), Br. J. Cancer, 2001, vol. 84, no. 1, pp. 3–10.
3. Cases, A., Darbepoetin alfa: a novel erythropoiesisstimulating protein, Drugs Today (Bare), 2003, vol. 39, pp. 477–495.
4. Macdougall, I.C., Darbepoetin alfa: a new therapeutic agent for renal anemia, Kidney Int. Suppl., 2002, vol. 80, pp. 55–61.
5. Carrera, F., Disney, A., and Molina, M., Extended dosing intervals with erythropoiesis-stimulating agents in chronic kidney disease: a review of clinical data, Nephrol. Dial. Transplant., 2007, vol. 22, no. 4, pp. 19–30.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献